|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"許駿"
Showing items 91-115 of 148 (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page
| 國立臺灣大學 |
2009 |
Adjuvant Interferon Therapy after Curative Therapy for Hepatocellular Carcinoma (Hcc): A Meta-Analysis
|
許駿; 沈盈君; 陳立宗; 胡賦强; 鄭安理; HSU, CHIUN; SHEN, YING-CHUN; CHEN, LI-TZONG; HU, FU-CHANG; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Evaluation of Vandetanib in Patients with Inoperable Hepatocellular Carcinoma (Hcc): A Randomized, Double-Blind, Parallel Group, Multicentre, Phase Ii Study
|
許駿; 謝瑞坤; 黃偉修; 趙毅; 鄭安理; HSU, CHIUN; HSIEH, RUEY-KUN; HWANG, WEI-SHOU; CHAO, YEE; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Prognostic Factors of Survival in 236 Advanced Hepatocellular Carcinoma Patients Enrolled in Prospective Clinical Trials of Systemic Therapy
|
林宗哲; 邵幼雲; 徐志宏; 許駿; 洪瑞隆; 鄭安理; LIN, ZONG-ZHE; SHAO, YU-YUN; HSU, CHIH-HUNG; HSU, CHIUN; HONG, RUEY-LONG; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Strategies to Prevent Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Therapy
|
許駿; 魏淑鉁; 鄭安理; 陳培哲; HSU, CHIUN; WEI, SHU-CHEN; CHENG, ANN-LII; CHEN, PEI-JER |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Trail Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of P13k/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Phase Ii Study of Cetuximab Plus Weekly Cisplatin and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin for the First-Line Treatment of Advanced Gastric Cancer
|
葉坤輝; 徐志宏; 許駿; 林璟宏; 沈盈君; 邱宗傑; 趙毅; 鄭安理; YEH, KUN-HUEI; HSU, CHIH-HUNG; HSU, CHIUN; LIN, CHING-HUNG; SHEN, YING-CHUN; CHIOU, TZEON-JYE; CHAO, YEE; CHENG, ANN-LII |
| 國立臺灣大學 |
2008-07-31 |
肝癌之轉譯研究:探索分子標靶及治療方法－肝細胞癌之「節拍器式」化學治療藥物及抗血管新生分子靶向治療藥物之最佳化研究(子計畫六)(1/3)
|
許駿 |
| 國立臺灣大學 |
2008-06 |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin, Zhong-Zhe; Hsu, Chiun; Chang, Yeun-Chung; Yu, Chong-Jen; Hsu, Chih-Hung; Lin, Chia-Chi; Cheng, Ann-Lii; Yang, Pan-Chyr; Yang, Chih-Hsin; 林宗哲; 許駿; 張允中; 余忠仁; 徐志宏; 林家齊; 鄭安理; 楊泮池; 楊志新 |
| 國立臺灣大學 |
2008 |
Expression of Mitosis Regulatory Proteins in Biliary Tract Carcinoma: Correlation with Clinico-Pathological Features and Patient Outcome
|
沈盈君; 胡賦強; 鄭永銘; 張玉憲; 林宗哲; 張明志; 許駿; 鄭安理; SHEN, YING-CHUN; HU, FU-CHANG; JENG, YUNG -MING; CHANG, YU-SHIAHN; LIN, ZONG-ZHE; CHANG, MING-CHIH; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Comparison of Hypoplastic Myelodysplastic Syndrome (Mds) with Normo-/ Hypercellular Mds by International Prognostic Scoring System, Cytogenetic and Genetic Studies
|
黃泰中; 柯博升; 唐季祿; 許駿; 陳建源; 蔡偉; 黃聖懿; 姚明; 陳耀昌; 沈銘鏡; 王秋華; 田蕙芬; HUANG, TAI-CHUNG; KO, BO-SHENG; TANG, JIH-LUH; HSU, CHIUN; CHEN, CHIEN-YUAN; TSAY, WOEI; HUANG, SHANG-YI; YAO, MING; CHEN, YAO-CHANG; SHEN, MING- CHING; WANG, CHIU-HWA; TIEN, HWEI-FANG |
| 國立臺灣大學 |
2008 |
A Revisit of Prophylactic Lamivudine for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin's Lymphoma: A Randomized Trial
|
許駿; 熊昭; 蘇益仁; 黃偉修; 張明志; 李啟誠; 巫宏博; 田蕙芬; 趙祖怡; 鄭安理; 陳培哲; HSU, CHIUN; HSIUNG, CHAO A.; SU, IH-JEN; HWANG, WEI-SHOU; CHANG, MING-CHIH; LI, CHI-CHENG; WU, HUNG-BO; TIEN, HWEI-FANG; CHAO, TSU-YI; CHENG, ANN -LII; CHEN, PEI-JER |
| 國立臺灣大學 |
2008 |
Expression of the Nuclear Factor Kappa B (Nfkb) P50/P65 Proteins in Hepatocellular Carcinoma (Hcc): Lack of Predictive Value for Response to Thalidomide Treatment
|
許駿; 陳立宗; 趙毅; 沈盈君; 鄭安理; HSU, CHIUN; CHEN, LI-TZONG; CHAO, YEE; SHEN, YING-CHUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Forkhead Box Transcription Factor Foxo3a Suppresses Estrogen-Dependent Breast Cancer Cell Proliferation and Tumorigenesis
|
鄭建睿; 許駿; CHENG, CHIEN-JUI; HSU, CHIUN |
| 國立臺灣大學 |
2008 |
Gemcitabine Plus Conventional-Dose Epirubicin Versus Gemcitabine Plus Cisplatin as First-Line Chemotherapy for Stage Iiib/Iv Non-Small Cell Lung Carcinoma-a Randomized Phase Ii Trial
|
許駿; 郭頌鑫; 胡賦强; 鄭安理; 施金元; 余忠仁; 林家齊; 楊泮池; 楊志新; HSU, CHIUN; KUO, SUNG-HSIN; HU, FU-CHANG; CHENG, ANN-LII; SHIH, JIN-YUAN; YU, CHONG-JEN; LIN, CHIA-CHI; YANG, PAN-CHYR; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2008 |
Geographic Difference in Clinical Trial Practice for Advanced Hepatocellular Carcinoma (Hcc): Implications on Trial Design of Global Scale
|
許駿; 沈盈君; 胡賦强; 鄭安理; HSU, CHIUN; SHEN, YING-CHUN; HU, FU-CHANG; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Imaging Adjustment with Dosimetric Verification of Cone-Beam Ct in Head and Neck Cancer Patient
|
許駿; 吳簡坤; 趙曉玲; 王駿瑋; 蔡巧琳; 成佳憲; HSU, CHIUN; WU, JIAN-KUEN; CHAO, HSIAO-LING; WANG, CHUN-WEI; TSAI, CHIAO-LING; CHENG, JASON CHIA-HSIEN |
| 國立臺灣大學 |
2008 |
Phase Ii Study of Sorafenib Plus Tegafur/Uracil (Uft) in Patients with Advanced Hepatocellular Carcinoma (Hcc)
|
沈盈君; 邵幼雲; 徐志宏; 許駿; 林宗哲; 陳培哲; 丁雅慧; 鄭安理; SHEN, YING-CHUN; SHAO, YU-YUN; HSU, CHIH-HUNG; HSU, CHIUN; LIN, ZONG-ZHE; CHEN, PEI-JER; DING, YEA-HUI; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Predictors of Toxicity of Weekly Docetaxel in Chemotherapy-Treated Non- Small Cell Lung Cancers
|
陳若白; 羅英; 余忠仁; 許駿; 施金元; 楊志新; CHEN, JO-PAI; LO, YIN; YU, CHONG-JEN; HSU, CHIUN; SHIH, JIN-YUAN; YANG, CHIH-HSIN; YANG, CHIH- HSIN |
| 國立臺灣大學 |
2008 |
Reconstructed Volume Loss on Cone-Beam Ct Images of Moving Targets
|
趙曉玲; 許駿; 吳簡坤; 成佳憲; CHAO, HSIAO-LING; HSU, CHIUN; WU, JIAN-KUEN; CHENG, JASON CHIA-HSIEN |
| 國立臺灣大學 |
2008 |
Weekly Cisplatin, Infusional High-Dose 5-Fluorouracil and Leucovorin for Advanced, Recurrent and Metastatic Cervical Carcinoma
|
蕭聖謀; 陳祈安; 許駿; 林鶴雄; 謝長堯; 魏凌鴻; HSIAO, SHENG-MOU; CHEN, CHI-AN; HSU, CHIUN; LIN, HO-HSIUNG; HSIEH, CHANG-YAO; WEI, LIN-HUNG |
| 國立臺灣大學 |
2008 |
Sorafenib Overcomes Bortezomib Resistance of Hepatocellular Carcinoma Cells by down-Regulating Phospho-Akt and Bcl-2
|
陳昆鋒; 許駿; 徐志宏; 葉培彥; 李水盛; 陳培哲; 鄭安理; CHEN, KUEN-FENG; HSU, CHIUN; HSU, CHIH-HUNG; YEH, PEI-YEN; LEE, SHOEI-SHENG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2007 |
Comparison of Hypoplastic Myelodysplastic Syndrome with Normo-/ Hypercellular Mds by International Prognostic Scoring System, Cytogenetic and Genetic Studies
|
田蕙芬; 柯博升; 許駿; 陳建源; 蔡偉; 唐季祿; 黃聖懿; 姚明; 陳耀昌; 沈銘鏡; 王秋華; TIEN, HWEI-FANG; KO, PO-SHENG; HSU, CHIUN; CHEN, CHIEN-YUAN; TSAY, WOEI; TANG, JIH- LUH; HUANG, SHANG-YI; YAO, MING; CHEN, YAO-CHANG; SHEN, MING-CHING; WANG, CHIU-HWA |
| 國立臺灣大學 |
2007 |
Dynamic Mri Signals in the Second Week of Radiotherapy Relate to Treatment Outcomes of Hepatocellular Carcinoma: A Preliminary Result
|
梁博欽; 常慧如; 許駿; 曾鑠鑠; 施庭芳; 劉滄梧; LIANG, PO-CHIN; CHANG, HUI-JU; HSU, CHIUN; TSENG, SHUO-SHUO; SHIH, TIFFANY TING-FANG; LIU, TSANG-WU |
| 國立臺灣大學 |
2007 |
Arsenic Trioxide in Patients with Hepatocellular Carcinoma: A Phase Ii Trial
|
林家齊; 許駿; 徐志宏; 許瑋玲; 鄭安理; 楊志新; LIN, CHIA-CHI; HSU, CHIUN; HSU, CHIH-HUNG; HSU, WEI-LING; CHENG, ANN-LII; YANG, CHIH-HSIN |
Showing items 91-115 of 148 (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page
|
